SCHEMBL17036992

SCHEMBL17036992

c1ccc(-c2cccc3c2oc2c(-c4ccc(C5(c6ccc(-c7cccc8c7oc7ccccc78)cc6)c6ccccc6-c6ccccc65)cc4)cccc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
OPRK1 P41145 1/20 0.41
GGPS1 O95749 1/20 0.40
PRKDC P78527 7/20 0.38
PTGES2 Q9H7Z7 1/20 0.38
CDC14B O60729 2/20 0.36
CDC14A Q9UNH5 2/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
TP53 P04637 2/20 0.34
CYP3A4 P08684 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
NPC1 O15118 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440064 0.97 ALOX5 (0.50) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL29572728 0.96 ALOX5 (0.51) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL371292 0.96 ALOX5 (0.51) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL438618 0.96 ALOX5 (0.51) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL437623 0.96 ALOX5 (0.54) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL438612 0.95 ALOX5 (0.50) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL16182135 0.94 ALOX5 (0.52) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL438642 0.94 ALOX5 (0.52) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL437624 0.93 KDM4E (0.46) ALOX5SMN1; SMN2MEN1MAPTKMT2A
SCHEMBL440035 0.92 KDM4E (0.45) ALOX5SMN1; SMN2MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150243899-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-08-27 US disclosed
US-20150243899-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2015-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243899-A1 Fluorene Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Lighting Device, and Organic Compound CYP1A1, CYP1B1, DRD1 ALOX5 1299/4885SMN1; SMN2 3413/4885MEN1 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.